Catalent Launches New Service for End-to-End Supply Chain Case Management of Cell and Gene Therapies

Published on :

Catalent, the leader in enabling the development and supply of better treatments for patients worldwide, today announced the launch of its new Case Management Service, which has been specifically designed to address the unique challenges associated with the safe and timely delivery of advanced therapies to patients by providing professional supply chain oversight from program start to finish.